Influence of aging on serum phenytoin concentrations: a pharmacokinetic analysis based on therapeutic drug monitoring data
Authors:
- Dina BattinoDBDina Battino
- Danilo CrociDCDanilo Croci
- Daniela MamoliDMDaniela Mamoli
- Sara MessinaSMSara Messina
- Emilio PeruccaEPEmilio Perucca
- 1 April 2004
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 59 (2-3) , 155-165
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Variability of total phenytoin serum concentrations within elderly nursing home residentsNeurology, 2003
- Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsyEpilepsy Research, 1999
- Differential kinetics of phenytoin in elderly patients.Drugs & Aging, 1999
- Therapeutic Monitoring: Revised Winter–Tozer Equation for Normalized Phenytoin Concentrations in Trauma and Elderly Patents with HypoalbuminemiaAnnals of Pharmacotherapy, 1997
- Antiepileptics in the elderly. Pharmacoepidemiology and pharmacokineticsArchives of Family Medicine, 1994
- Increased Free Phenytoin Concentrations in Predialysis Serum Compared to Postdialysis Serum in Patients with Uremia Treated with Hemodialysis: Role of Uremic CompoundsAmerican Journal of Clinical Pathology, 1992
- Identifying Patients Who Might Benefit from Free Phenytoin MonitoringTherapeutic Drug Monitoring, 1987
- Age and phenytoin kinetics in adult epilepticsClinical Pharmacology & Therapeutics, 1982
- Disposition of Antipyrine and Phenytoin Correlated with Age and Liver Volume in ManClinical Pharmacokinetics, 1981
- Concurrent administration of phenobarbital and diphenylhydantoinNeurology, 1971